Home

Settlers perturbație Opt carta 2003 levodopa gad Standard Tractor Rău de mare

Parkinson's Disease Therapeutics: New Developments and Challenges Since the  Introduction of Levodopa | Neuropsychopharmacology
Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa | Neuropsychopharmacology

Comparative effects of acute or chronic administration of levodopa to  6-hydroxydopamine-lesioned rats on the expression of glutamic acid  decarboxylase in the neostriatum and GABAA receptors subunits in the  substantia nigra, pars reticulata -
Comparative effects of acute or chronic administration of levodopa to 6-hydroxydopamine-lesioned rats on the expression of glutamic acid decarboxylase in the neostriatum and GABAA receptors subunits in the substantia nigra, pars reticulata -

Levodopa pharmacokinetics -from stomach to brain : A study on patients with  Parkinson's disease
Levodopa pharmacokinetics -from stomach to brain : A study on patients with Parkinson's disease

µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's  Disease | Journal of Neuroscience
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease | Journal of Neuroscience

PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra  Pars Compacta in Parkinson's Disease
PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease

Anxiety: An ignored aspect of Parkinson's disease lacking attention -  ScienceDirect
Anxiety: An ignored aspect of Parkinson's disease lacking attention - ScienceDirect

µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's  Disease | Journal of Neuroscience
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease | Journal of Neuroscience

The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson's Disease |  Pharmacological Reviews
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson's Disease | Pharmacological Reviews

Concomitant short‐ and long‐duration response to levodopa in the  6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 -  European Journal of Neuroscience - Wiley Online Library
Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 - European Journal of Neuroscience - Wiley Online Library

Frontiers | Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of  Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced  Dyskinesia
Frontiers | Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia

PDF) Serotonergic mechanisms responsible for levodopa-induced dyskinesias  in Parkinson's disease patients
PDF) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients

Signal transduction in l-DOPA-induced dyskinesia: from receptor  sensitization to abnormal gene expression | SpringerLink
Signal transduction in l-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression | SpringerLink

Frontiers | Advances in non-dopaminergic treatments for Parkinson's disease
Frontiers | Advances in non-dopaminergic treatments for Parkinson's disease

Levodopa pharmacokinetics -from stomach to brain : A study on patients with  Parkinson's disease
Levodopa pharmacokinetics -from stomach to brain : A study on patients with Parkinson's disease

Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving  concepts - Espay - 2018 - Annals of Neurology - Wiley Online Library
Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts - Espay - 2018 - Annals of Neurology - Wiley Online Library

Systems-level neurophysiological state characteristics for drug evaluation  in an animal model of levodopa-induced dyskinesia | Journal of  Neurophysiology
Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia | Journal of Neurophysiology

Anxiety: An ignored aspect of Parkinson's disease lacking attention -  ScienceDirect
Anxiety: An ignored aspect of Parkinson's disease lacking attention - ScienceDirect

Anxiety: An ignored aspect of Parkinson's disease lacking attention -  ScienceDirect
Anxiety: An ignored aspect of Parkinson's disease lacking attention - ScienceDirect

Levodopa-Induced Dyskinesia in Parkinson's Disease
Levodopa-Induced Dyskinesia in Parkinson's Disease

PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra  Pars Compacta in Parkinson's Disease
PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease

The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson's Disease |  Pharmacological Reviews
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson's Disease | Pharmacological Reviews

Increased adenosine A2A receptors in the brain of Parkinson's disease  patients with dyskinesias
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias

Frontiers | A Multi-Scale Computational Model of Levodopa-Induced Toxicity  in Parkinson's Disease
Frontiers | A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease

PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra  Pars Compacta in Parkinson's Disease
PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease

β-asarone and levodopa coadministration increases striatal levels of  dopamine and levodopa and improves behavioral competence in Parkinson's rat  by enhancing dopa decarboxylase activity - ScienceDirect
β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity - ScienceDirect